These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8445238)

  • 1. Estradiol-17 beta-glucuronide-induced cholestasis. Effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate.
    Sano N; Takikawa H; Yamanaka M
    J Hepatol; 1993 Feb; 17(2):241-6. PubMed ID: 8445238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithocholate-3-O-glucuronide-induced cholestasis. A study with congenital hyperbilirubinemic rats and effects of ursodeoxycholate conjugates.
    Takikawa H; Minagawa K; Sano N; Yamanaka M
    Dig Dis Sci; 1993 Aug; 38(8):1543-8. PubMed ID: 8344113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts.
    Utili R; Tripodi MF; Adinolfi LE; Gaeta GB; Abernathy CO; Zimmerman HJ
    Hepatology; 1990 May; 11(5):735-42. PubMed ID: 2347547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ursodeoxycholate and its conjugates on biliary glutathione excretion in rats.
    Takikawa H; Sano N; Yamanaka M
    Dig Dis Sci; 1996 Oct; 41(10):1953-8. PubMed ID: 8888706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced biliary excretion of lithocholate-3-sulfate by ursodeoxycholate-3,7-disulfate infusion in Eisai hyperbilirubinemic rat (EHBR).
    Takikawa H; Sano N; Ogasawara T; Yamanaka M
    Dig Dis Sci; 1998 Jan; 43(1):188-92. PubMed ID: 9508524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ursodeoxycholate, its glucuronide and disulfate and beta-muricholate on biliary bicarbonate concentration and biliary lipid excretion.
    Takikawa H; Sano N; Minagawa K; Yamanaka M
    J Hepatol; 1992 May; 15(1-2):77-84. PubMed ID: 1506660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ursodeoxycholate-3,7-disulfate on biliary excretion of lithocholate-3-O-glucuronide in Eisai hyperbilirubinemic rat (EHBR).
    Hasegawa Y; Takikawa H
    Hepatol Res; 2002 Aug; 23(4):296. PubMed ID: 12191677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ursodeoxycholate dose-dependent formation of ursodeoxycholate-glucuronide in the rat and the choleretic potencies.
    Takikawa H; Sano N; Narita T; Yamanaka M
    Hepatology; 1990 May; 11(5):743-9. PubMed ID: 2347548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of estradiol-17 beta-D-glucuronide-induced cholestasis by sodium tauroursodeoxycholate therapy in rats.
    Kinbara S; Ishizaki K; Sakakura H; Hirabayashi N; Kasai H; Araki T
    Scand J Gastroenterol; 1997 Sep; 32(9):947-52. PubMed ID: 9299676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different protective effects of tauroursodeoxycholate, ursodeoxycholate, and 23-methyl-ursodeoxycholate against taurolithocholate-induced cholestasis.
    Baumgartner U; Schölmerich J; Sellinger M; Reinhardt M; Ruf G; Farthmann EH
    Dig Dis Sci; 1996 Feb; 41(2):250-5. PubMed ID: 8601366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliary excretion of bile acid conjugates in a hyperbilirubinemic mutant Sprague-Dawley rat.
    Takikawa H; Sano N; Narita T; Uchida Y; Yamanaka M; Horie T; Mikami T; Tagaya O
    Hepatology; 1991 Aug; 14(2):352-60. PubMed ID: 1860692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary excretion of tauroursodeoxycholate-3-sulfate in the rat.
    Akimoto K; Sano N; Takikawa H
    Steroids; 2001 Sep; 66(9):701-5. PubMed ID: 11546558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic index of taurocholate or tauroursodeoxycholate in experimental drug-induced cholestasis.
    Utili R; Adinolfi LE; Tripodi MF
    Ital J Gastroenterol; 1995; 27(6):332-4. PubMed ID: 8563000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary excretion of estradiol-17 beta-glucuronide in the rat.
    Takikawa H; Yamazaki R; Sano N; Yamanaka M
    Hepatology; 1996 Mar; 23(3):607-13. PubMed ID: 8617443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of organic anions and bile acids on biliary lipid excretion in hyperbilirubinemic mutant Sprague-Dawley rats.
    Takikawa H; Sano N; Wako Y; Yamanaka M
    J Hepatol; 1993 Feb; 17(2):247-52. PubMed ID: 8445239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis.
    Sánchez Pozzi EJ; Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Rodríguez Garay EA; Mottino AD
    J Pharmacol Exp Ther; 2003 Jul; 306(1):279-86. PubMed ID: 12663690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The choleretic effects of N-acetylglucosaminides, major urinary metabolites of ursodeoxycholic acid, in bile fistula rats.
    Iwaki T; Hirabayashi N; Miyazawa N; Takeuchi Y; Ishizaki K; Sakakura H; Kasai H; Maeda M; Araki T
    Eur J Pharmacol; 1998 Dec; 363(1):41-8. PubMed ID: 9877080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats.
    Tsukahara K; Kanai S; Ohta M; Kitani K
    Liver; 1993 Oct; 13(5):262-9. PubMed ID: 8259039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine inhibits lithocholate-3-O-glucuronide-induced cholestasis in rats.
    Takikawa H; Sano N; Yamazaki R; Yamanaka M
    J Hepatol; 1995 Jan; 22(1):88-93. PubMed ID: 7751593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of hepatobiliary transport for conjugated metabolites in the perfused liver of mutant rats (EHBR) with hereditary conjugated hyperbilirubinemia.
    Takenaka O; Horie T; Kobayashi K; Suzuki H; Sugiyama Y
    Pharm Res; 1995 Nov; 12(11):1746-55. PubMed ID: 8592681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.